Smartlens
Founded 2015 · 15 employees on LinkedIn · 2 known investors
Smartlens develops ophthalmic technologies for anterior segment disease management, including miLens, a non-invasive wearable microfluidic contact lens for remote intraocular pressure monitoring, an AI-powered remote examination platform for anterior segment conditions, and an automated micro-dose medication delivery device. Its products serve glaucoma and chronic eye disease care, combining continuous monitoring, AI-based diagnostics, and treatment optimization for clinicians and patients.
Investors · 2
Frequently asked questions
- What does Smartlens do?
- Smartlens develops ophthalmic technologies for anterior segment disease management, including miLens, a non-invasive wearable microfluidic contact lens for remote intraocular pressure monitoring, an AI-powered remote examination platform for anterior segment conditions, and an automated micro-dose medication delivery device. Its products serve glaucoma and chronic eye disease care, combining continuous monitoring, AI-based diagnostics, and treatment optimization for clinicians and patients.
- Who are Smartlens's investors?
- Smartlens's investors include 3E Bioventures Capital, Ambit Health Ventures.